异动解读｜波士顿科学盘中上涨3.01%，两款新产品在华获批提振市场情绪

行情直击08-22

8月22日，波士顿科学盘中上涨3.01%，报50.855美元/股，成交额7.66亿美元。

消息面上，公司近日接连获得中国国家药监局批准：新一代热蒸汽治疗设备Rezūm EVO在华获批，中国成为该产品全球首批获批市场；同时上海临港工厂生产的新一代FARASTAR心脏脉冲电场消融系统也正式获批，从受理到获批创下公司在华本土设备项目最快纪录，较以往同类项目审批周期缩短约1.5个月。两项获批标志着公司本土化生产范围从高端介入耗材拓展至复杂设备平台，为此前因Watchman业务放缓及全年指引下调持续承压的股价带来阶段性修复动力。

（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/1158122087?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-08-22 00:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1158122087","market":"hk","top_or_hot":-1,"title":"异动解读｜波士顿科学盘中上涨3.01%，两款新产品在华获批提振市场情绪","media":"行情直击","content":"<p><p>8月22日，波士顿科学盘中上涨3.01%，报50.855美元/股，成交额7.66亿美元。</p><p>消息面上，公司近日接连获得中国国家药监局批准：新一代热蒸汽治疗设备Rezūm EVO在华获批，中国成为该产品全球首批获批市场；同时上海临港工厂生产的新一代FARASTAR心脏脉冲电场消融系统也正式获批，从受理到获批创下公司在华本土设备项目最快纪录，较以往同类项目审批周期缩短约1.5个月。两项获批标志着公司本土化生产范围从高端介入耗材拓展至复杂设备平台，为此前因Watchman业务放缓及全年指引下调持续承压的股价带来阶段性修复动力。</p><p>（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读｜波士顿科学盘中上涨3.01%，两款新产品在华获批提振市场情绪</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读｜波士顿科学盘中上涨3.01%，两款新产品在华获批提振市场情绪\n</h2>\n\n<h4 class=\"meta\">\n\n2026-08-22 00:13 北京时间&nbsp;&nbsp;&nbsp;<strong>行情直击</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>8月22日，波士顿科学盘中上涨3.01%，报50.855美元/股，成交额7.66亿美元。消息面上，公司近日接连获得中国国家药监局批准：新一代热蒸汽治疗设备Rezūm EVO在华获批，中国成为该产品全球首批获批市场；同时上海临港工厂生产的新一代FARASTAR心脏脉冲电场消融系统也正式获批，从受理到获批创下公司在华本土设备项目最快纪录，较以往同类项目审批周期缩短约1.5个月。两项获批标志着公司本土化...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BSX","symbol_name":"波士顿科学","start_time":0,"source_url":"","article_id":"1158122087","we_media_id":"1059448697","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1158122087","pubTimestamp":1787328790,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"行情直击","introduction":"个股异动一手消息解读","home_visible":1,"id":"1059448697","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"8月22日，波士顿科学盘中上涨3.01%，报50.855美元/股，成交额7.66亿美元。两项获批标志着公司本土化生产范围从高端介入耗材拓展至复杂设备平台，为此前因Watchman业务放缓及全年指引下调持续承压的股价带来阶段性修复动力。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BSX":"波士顿科学"},"translate_title":"Interpretation of the change | Boston Scientific rose 3.01% in the intraday session, and two new products were approved in China to boost market sentiment","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BSX":1},"content_text":"8月22日，波士顿科学盘中上涨3.01%，报50.855美元/股，成交额7.66亿美元。消息面上，公司近日接连获得中国国家药监局批准：新一代热蒸汽治疗设备Rezūm EVO在华获批，中国成为该产品全球首批获批市场；同时上海临港工厂生产的新一代FARASTAR心脏脉冲电场消融系统也正式获批，从受理到获批创下公司在华本土设备项目最快纪录，较以往同类项目审批周期缩短约1.5个月。两项获批标志着公司本土化生产范围从高端介入耗材拓展至复杂设备平台，为此前因Watchman业务放缓及全年指引下调持续承压的股价带来阶段性修复动力。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1158122087","isCrawlerRequest":true}